Clinical Trial Update: Single Ascending Dose Study of RBP-7000 [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study of RBP-7000 in schizophrenia completed; results are not detailed in the snippet provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RBP-7000

Snippet

Sponsor: Indivior Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED